Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May 28;130(21):6706-7.
doi: 10.1021/ja8018687. Epub 2008 May 1.

Inhibitors of UDP-galactopyranose Mutase Thwart Mycobacterial Growth

Affiliations

Inhibitors of UDP-galactopyranose Mutase Thwart Mycobacterial Growth

Emily C Dykhuizen et al. J Am Chem Soc. .

Abstract

Galactofuranose (Galf) residues are fundamental components of the cell wall of mycobacteria. A key enzyme, UDP-galactopyranose mutase (UGM), that participates in Galf incorporation mediates isomerization of UDP-Galf from UDP-galactopyranose (UDP-Galp). UGM is of special interest as a therapeutic target because the gene encoding it is essential for mycobacterial viability and there is no comparable enzyme in humans. We used structure-activity relationships and molecular design to devise UGM inhibitors. From a focused library of synthetic aminothiazoles, several compounds that block the UGM from Klebsiella pneumoniae or Mycobacterium tuberculosis were identified. These inhibitors block the growth of M. smegmatis.

Similar articles

See all similar articles

Cited by 31 articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback